Evidence map›Paper›PMID 39398892›Full record

ArticleDigital health

Bridging the gap: Leveraging telemedicine and IT infrastructure to connect outpatient oncology practices with specialized expert teams in the management of rare tumors.

Julia Kasprzak, Timothy Goering, Karin Berger-Thürmel, Vanessa Kratzer, Wuthichai Prompinit, Sven P Wichert, Simon Leutner, Norbert Langermann, Michael von Bergwelt-Baildon, Volker Heinemann and 4 more

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Julia KasprzakComprehensive Cancer Center Munich, LMU University Hospital, LMU Munich, Munich, Germany.ORCID https://orcid.org/0000-0002-9511-606X
Timothy GoeringKAIROS GmbH - an IQVIA business, Bochum, Germany.ORCID https://orcid.org/0009-0000-9570-4374
Karin Berger-ThürmelDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Vanessa KratzerComprehensive Cancer Center Munich, LMU University Hospital, LMU Munich, Munich, Germany.
Wuthichai PrompinitComprehensive Cancer Center Munich, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Sven P WichertDepartment of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Munich, Germany.
Simon LeutnerDepartment of Medical Technology and IT, LMU University Hospital, LMU Munich, Munich, Germany.
Norbert LangermannKAIROS GmbH - an IQVIA business, Bochum, Germany.
Michael von Bergwelt-BaildonDepartment of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.
Volker HeinemannComprehensive Cancer Center Munich, LMU University Hospital, LMU Munich, Munich, Germany.
Hana AlgülComprehensive Cancer Center Munich, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Martin ZünkelerKAIROS GmbH - an IQVIA business, Bochum, Germany.
Daniel NassehComprehensive Cancer Center Munich, LMU University Hospital, LMU Munich, Munich, Germany.
TARGET Group *

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The treatment of rare tumors often necessitates the involvement of highly specialized teams, typically based in larger medical centers or university hospitals, which are often lacking in rural areas. The German TARGET (the Trans-sectoral Personalized Care Concept for Patients with Rare Cancers) project aims to improve the network between outpatient oncology practices and more centralized expert teams via telemedicine. Methods: The primary work involved conceptualizing the implementation of project requirements based on feedback from various TARGET project teams, and ultimately, the method of implementation using the software CentraXX. Key requirements included the utilization of an electronic health record (EHR), incorporating appropriate access mediums such as smartphones, and utilizing user-specific certificates to ensure secure and tailored access. The implementation considered technical aspects, data protection regulations, and the need for user-friendly interfaces, particularly for older patients with cancer with limited technological proficiency. Results: The results detail the successful implementation of the project requirements using CentraXX, which facilitated the implementation of an EHR, access mediums (patient app), and browser access for outpatient doctors, addressing the project's technical, security, and usability needs. Conclusion: This article presents an overview of the requirements associated with the TARGET project and outlines how they were met in terms of the IT infrastructure. By focusing on the IT implementation rather than the medical trial results, this work aims to provide valuable insights and guidance for similar projects seeking to improve telemedicine networks and digital information exchange in the context of rare cancer treatment.

Indexed as

Electronic health recordoutreachpatient-reported outcometelemedicine

Identifiers

PMID39398892
PMCPMC11468480

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.